Assess Sacubitril/Allisartan and Amlodipine in Patients With Essential Hypertension Uncontrolled With Amlodipine
Clinical trial NCT07704684 · COMPLETED
Trial details
- NCT number
- NCT07704684
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-28
- Primary completion
- 2025-08-26
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.